MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$109,968K
Accounts receivable, net
$55,412K
Marketable securities
$30,306K
Inventories
$20,921K
Prepaid expenses and
other current assets
$19,530K
Restricted cash
$1,327K
Property and equipment,
gross
$5,278K
Total current assets
$237,464K
Right-of-use assets,
operating and finance...
$7,940K
Other non-current
assets
$7,493K
Property and equipment,
net
$616K
Restricted deposit
$177K
Less accumulated
depreciation and...
$4,662K
Total assets
$253,690K
Accumulated deficit
-$983,290K
Total liabilities and
shareholders' deficit
$253,690K
Total shareholders'
deficit
-$124,253K
Additional paid-in capital
$858,895K
Ordinary shares, nis 0.01
par value,...
$134K
Accumulated other
comprehensive income
$8K
Total liabilities
$377,943K
Long-term debt
$189,530K
Prepaid forward
obligation
$128,228K
Total current
liabilities
$50,635K
Lease, liabilities,
noncurrent
$5,647K
Uncertain tax positions
liability
$3,903K
Accounts payable and
accrued expenses
$35,346K
Employee related accrued
expenses
$9,837K
Other liabilities,
current
$5,452K
Back
Back
Balance Sheet
source: myfinsight.com
UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN)